Latest filing published 19 Feb 2025 for Inari Medical, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by William Hoffman on record concern Inari Medical, Inc., in the capacity of senior executive. The record holds 79 filings, for trades running from 27 May 2020 to 19 February 2025.
In open-market terms, that means 1 purchase worth €226k on one side and 47 sales worth €40.6M on the other. Taken together, the sales exceed the purchases by €40.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 15 share grants and 13 option exercises. 2025 to date brings no purchases and 1 sale.
The newest entry dates from 19 February 2025: a transaction, in Inari Medical, Inc. The most recent open-market purchase was published on 27 May 2020, 2,338 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 75 declarations